These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10357210)

  • 1. Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients.
    Kuwabara I; Maruyama H; Kamisue S; Shima M; Yoshioka A; Maruyama IN
    J Immunol Methods; 1999 Apr; 224(1-2):89-99. PubMed ID: 10357210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
    Kahle J; Orlowski A; Stichel D; Becker-Peters K; Kabiri A; Healey JF; Brettschneider K; Naumann A; Scherger AK; Lollar P; Schwabe D; Königs C
    Thromb Haemost; 2015 Feb; 113(2):396-405. PubMed ID: 25520269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
    Lebreton A; Moreau V; Lapalud P; Cayzac C; André S; Nguyen C; Schved JF; Lavigne G; Granier C
    Br J Haematol; 2011 Nov; 155(4):487-97. PubMed ID: 21933172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel factor VIII inhibitor epitopes using synthetic peptide arrays.
    Palmer DS; Dudani AK; Drouin J; Ganz PR
    Vox Sang; 1997; 72(3):148-61. PubMed ID: 9145485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping of factor VIII inhibitor antibodies of Chinese origin.
    Huang CC; Shen MC; Chen JY; Hung MH; Hsu TC; Lin SW
    Br J Haematol; 2001 Jun; 113(4):915-24. PubMed ID: 11442484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide.
    Ware J; MacDonald MJ; Lo M; de Graaf S; Fulcher CA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):703-16. PubMed ID: 1283342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain.
    Nogami K; Shima M; Giddings JC; Takeyama M; Tanaka I; Yoshioka A
    Int J Hematol; 2007 May; 85(4):317-22. PubMed ID: 17483075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site.
    Pratt KP; Qian J; Ellaban E; Okita DK; Diethelm-Okita BM; Conti-Fine B; Scott DW
    Thromb Haemost; 2004 Sep; 92(3):522-8. PubMed ID: 15351848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-predicted peptides that mimic discontinuous epitopes on the A2 domain of factor VIII.
    Lebreton A; Simon N; Moreau V; Demolombe V; Cayzac C; Nguyen C; Schved JF; Granier C; Lavigne-Lissalde G
    Haemophilia; 2015 May; 21(3):e193-e201. PubMed ID: 25422151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the human factor VIII A2 inhibitor epitope by alanine scanning mutagenesis.
    Lubin IM; Healey JF; Barrow RT; Scandella D; Lollar P
    J Biol Chem; 1997 Nov; 272(48):30191-5. PubMed ID: 9374501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
    Behrmann M; Pasi J; Saint-Remy JM; Kotitschke R; Kloft M
    Thromb Haemost; 2002 Aug; 88(2):221-9. PubMed ID: 12195693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
    Yada K; Nogami K; Shima M
    Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common inhibitory effects of human anti-C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor.
    Shima M; Nakai H; Scandella D; Tanaka I; Sawamoto Y; Kamisue S; Morichika S; Murakami T; Yoshioka A
    Br J Haematol; 1995 Nov; 91(3):714-21. PubMed ID: 8555081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequence.
    Shibata M; Shima M; Morichika S; McVey J; Tuddenham EG; Tanaka I; Suzuki H; Nogami K; Minamoto Y; Hato T; Saenko EL; Scandella D; Yoshioka A
    Thromb Haemost; 2000 Sep; 84(3):442-8. PubMed ID: 11019969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries.
    Schmidt A; Brettschneider K; Kahle J; Orlowski A; Becker-Peters K; Stichel D; Schulze J; Braner M; Tampé R; Schwabe D; Königs C
    Thromb Haemost; 2016 Jul; 116(1):32-41. PubMed ID: 27009573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
    Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
    Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of a major inhibitor epitope in factor VIII.
    Lubin IM; Healey JF; Scandella D; Runge MS; Lollar P
    J Biol Chem; 1994 Mar; 269(12):8639-41. PubMed ID: 7510693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
    Nogami K; Shima M; Nishiya K; Sakurai Y; Tanaka I; Giddings JC; Saenko EL; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.